APA (7th ed.) Citation

H, M., Y, A., J, K., T, K., ML, S., M, M., . . . A, T. (2026). Survival in adults with high-risk TA-TMA: A comparative analysis of narsoplimab vs supportive care. Blood advances, 10(1), 111. https://doi.org/10.1182/bloodadvances.2025017540

Chicago Style (17th ed.) Citation

H, Matsui, et al. "Survival in Adults with High-risk TA-TMA: A Comparative Analysis of Narsoplimab Vs Supportive Care." Blood Advances 10, no. 1 (2026): 111. https://doi.org/10.1182/bloodadvances.2025017540.

MLA (9th ed.) Citation

H, Matsui, et al. "Survival in Adults with High-risk TA-TMA: A Comparative Analysis of Narsoplimab Vs Supportive Care." Blood Advances, vol. 10, no. 1, 2026, p. 111, https://doi.org/10.1182/bloodadvances.2025017540.